LC-812 series

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLC-812 series
Drug Alias Namenatural products for hematological disorders/disease(Leuchemix)
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeuchemix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeuchemix
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A